Intensive hospital monitoring of adverse reactions to benzodiazepines and neuroleptics;Monitoraggio intensivo ospedaliero delle reazioni avverse da benzodiazepine e neurolettici

Minerva Medica

Volumn 89, Issue 7-8, 1998, Pages 293-300

  Mangrella, M ^a   Motola, G ^a   Russo, F ^a   Mazzeo, F ^a   Falcone, G ^a   D'Alessio, O ^a   Piucci, B ^a   Rossi, F ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Adverse drug reaction reporting systems; Antipsychotic agents adverse effects; Benzodiazepines adverse effects; Drug monitoring; Italy epidemiology

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CHLORPROMAZINE; CLOPENTHIXOL; CLOTIAPINE; CLOZAPINE; DELORAZEPAM; FLURAZEPAM; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; PRAZEPAM; ZUCLOPENTHIXOL;

ADVERSE DRUG REACTION; AKATHISIA; ARTICLE; DRUG SURVEILLANCE PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MUSCLE RIGIDITY; MUSCLE SPASM; OBSESSION; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PSYCHOSIS; SCHIZOPHRENIA; SEDATION; SOMNOLENCE; TACHYCARDIA; VISUAL FIELD DEFECT;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; HOSPITALIZATION; HUMANS; INCIDENCE; MONITORING, PHYSIOLOGIC;

EID: 0031787211     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Borda IT, Slone D, Jick H. Assessment of adverse reactions within a drug surveillance program. J Am Med Assoc 1968;205:99-101.
2. Ogilvie RJ, Ruedy J. Adverse drug reactions during hospitalization. Can Med Assoc J 1967;97:1450-7.
3. Hurwitz N, Wade OL. Intensive hospital monitoring of adverse reactions to drugs. Br Med J 1969;1:531-6.
4. Kurata JH, Overhage M, Gabrieli E, Jones JK. International data standards for hospital-based drug surveillance. MD Comput 1995;12:50-7.